How Obamacare Cost One Small Company Nearly Half Its Market Value

Exact Sciences, the maker of a new colon-cancer screening test, has lost half its market value this week because of a ruling by the U.S. Preventive Services Task Force, which has become a key player under Obamacare. Here's what it means for other small life sciences companies.